title: Amantadine treatment of a patient with anoxic brain injury.
abstract: An 18-year-old boy with anoxic brain injury, suffering from severe psychomotor inhibition, tetrarigidity and dystonia, was treated with amantadine in order to ameliorate his symptoms. Neuropsychological tests showed improvement in motor and cognitive functions.
authors.affiliation: Regional Centre of Pediatric Rehabilitation, Göteborg, Sweden.
authors.forename: K
authors.initials: K
authors.lastname: Edby
authors.forename: J
authors.initials: J
authors.lastname: Larsson
authors.forename: M
authors.initials: M
authors.lastname: Eek
authors.forename: L
authors.initials: L
authors.lastname: von Wendt
authors.forename: B
authors.initials: B
authors.lastname: Ostergård
mesh_terms: D000203:Activities of Daily Living / Q000523:psychology; D000293:Adolescent; D000547:Amantadine / Q000009:adverse effects / Q000627:therapeutic use*; D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001925:Brain Damage, Chronic / Q000188:drug therapy* / Q000209:etiology; D001930:Brain Injuries / Q000150:complications* / Q000188:drug therapy; D003444:Crush Syndrome / Q000150:complications* / Q000188:drug therapy; D005500:Follow-Up Studies; D006801:Humans; D002534:Hypoxia, Brain / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D019965:Neurocognitive Disorders / Q000188:drug therapy / Q000209:etiology; D009460:Neurologic Examination / Q000187:drug effects; D009483:Neuropsychological Tests; D010302:Parkinson Disease, Secondary / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000978:Antiparkinson Agents; D000547:Amantadine